Literature DB >> 22973048

Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure.

Justin R Bailey1, Sarah Laskey, Lisa N Wasilewski, Supriya Munshaw, Liam J Fanning, Elizabeth Kenny-Walsh, Stuart C Ray.   

Abstract

Extraordinary viral sequence diversity and rapid viral genetic evolution are hallmarks of hepatitis C virus (HCV) infection. Viral sequence evolution has previously been shown to mediate escape from cytotoxic T-lymphocyte (CTL) and neutralizing antibody responses in acute HCV infection. HCV evolution continues during chronic infection, but the pressures driving these changes are poorly defined. We analyzed plasma virus sequence evolution in 5.2-kb hemigenomes from multiple longitudinal time points isolated from individuals in the Irish anti-D cohort, who were infected with HCV from a common source in 1977 to 1978. We found phylogenetically distinct quasispecies populations at different plasma time points isolated late in chronic infection, suggesting ongoing viral evolution and quasispecies replacement over time. We saw evidence of early pressure driving net evolution away from a computationally reconstructed common ancestor, known as Bole1b, in predicted CTL epitopes and E1E2, with balanced evolution toward and away from the Bole1b amino acid sequence in the remainder of the genome. Late in chronic infection, the rate of evolution toward the Bole1b sequence increased, resulting in net neutral evolution relative to Bole1b across the entire 5.2-kb hemigenome. Surprisingly, even late in chronic infection, net amino acid evolution away from the infecting inoculum sequence still could be observed. These data suggest that, late in chronic infection, ongoing HCV evolution is not random genetic drift but rather the product of strong pressure toward a common ancestor and concurrent net ongoing evolution away from the inoculum virus sequence, likely balancing replicative fitness and ongoing immune escape.

Entities:  

Mesh:

Year:  2012        PMID: 22973048      PMCID: PMC3497661          DOI: 10.1128/JVI.01440-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 2.  Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.

Authors:  J Bukh; R H Miller; R H Purcell
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

3.  Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

Authors:  A U Neumann; N P Lam; H Dahari; D R Gretch; T E Wiley; T J Layden; A S Perelson
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

4.  Hepatitis C: global prevalence.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-11-14

Review 5.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.

Authors:  M Nei; T Gojobori
Journal:  Mol Biol Evol       Date:  1986-09       Impact factor: 16.240

7.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

Authors:  E Kenny-Walsh
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

8.  Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection.

Authors:  S A Villano; D Vlahov; K E Nelson; S Cohn; D L Thomas
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

9.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.

Authors:  M Martell; J I Esteban; J Quer; J Genescà; A Weiner; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  CD8 epitope escape and reversion in acute HCV infection.

Authors:  Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

View more
  16 in total

1.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

2.  Analysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by ultradeep pyrosequencing.

Authors:  Brendan A Palmer; Zoya Dimitrova; Pavel Skums; Orla Crosbie; Elizabeth Kenny-Walsh; Liam J Fanning
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

Review 3.  Can Broadly Neutralizing Monoclonal Antibodies Lead to a Hepatitis C Virus Vaccine?

Authors:  Valerie J Kinchen; Andrea L Cox; Justin R Bailey
Journal:  Trends Microbiol       Date:  2018-04-24       Impact factor: 17.079

Review 4.  Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design.

Authors:  Alexander W Tarr; Tanvi Khera; Kathrin Hueging; Julie Sheldon; Eike Steinmann; Thomas Pietschmann; Richard J P Brown
Journal:  Viruses       Date:  2015-07-17       Impact factor: 5.048

5.  Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development.

Authors:  Lize Cuypers; Guangdi Li; Christoph Neumann-Haefelin; Supinya Piampongsant; Pieter Libin; Kristel Van Laethem; Anne-Mieke Vandamme; Kristof Theys
Journal:  Virus Evol       Date:  2016-09-06

6.  High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease.

Authors:  Ditte L Hedegaard; Damien C Tully; Ian A Rowe; Gary M Reynolds; David J Bean; Ke Hu; Christopher Davis; Annika Wilhelm; Colin B Ogilvie; Karen A Power; Alexander W Tarr; Deirdre Kelly; Todd M Allen; Peter Balfe; Jane A McKeating
Journal:  J Hepatol       Date:  2016-08-13       Impact factor: 25.083

Review 7.  Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.

Authors:  Eric A Toth; Andrezza Chagas; Brian G Pierce; Thomas R Fuerst
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

Review 8.  Mechanisms of HCV resistance to broadly neutralizing antibodies.

Authors:  Nicole Frumento; Andrew I Flyak; Justin R Bailey
Journal:  Curr Opin Virol       Date:  2021-07-28       Impact factor: 7.121

9.  Analysis of Dengue Virus Genetic Diversity during Human and Mosquito Infection Reveals Genetic Constraints.

Authors:  October M Sessions; Andreas Wilm; Uma Sangumathi Kamaraj; Milly M Choy; Angelia Chow; Yuwen Chong; Xin Mei Ong; Niranjan Nagarajan; Alex R Cook; Eng Eong Ooi
Journal:  PLoS Negl Trop Dis       Date:  2015-09-01

10.  A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samples.

Authors:  Elizabeth M Batty; T H Nicholas Wong; Amy Trebes; Karène Argoud; Moustafa Attar; David Buck; Camilla L C Ip; Tanya Golubchik; Madeleine Cule; Rory Bowden; Charis Manganis; Paul Klenerman; Eleanor Barnes; A Sarah Walker; David H Wyllie; Daniel J Wilson; Kate E Dingle; Tim E A Peto; Derrick W Crook; Paolo Piazza
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.